Status: current, Defined. Date: 31-Aug 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2680371000168111 | Olmesart HCT 20/12.5 (GxP) (hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg) tablet, 10 tablets, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2680381000168114 | Olmesart HCT 20/12.5 (GxP) tablet, 10, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Olmesart HCT 20/12.5 (GxP) tablet, 10, blister pack | Is a | Olmesart HCT 20/12.5 (GxP) (hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg) tablet, 10 tablets (trade product pack) | true | Inferred relationship | Some | ||
| Olmesart HCT 20/12.5 (GxP) tablet, 10, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Olmesart HCT 20/12.5 (GxP) tablet, 10, blister pack | has TPUU | Olmesart HCT 20/12.5 (GxP) tablet | true | Inferred relationship | Some | 1 | |
| Olmesart HCT 20/12.5 (GxP) tablet, 10, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Olmesart HCT 20/12.5 (GxP) tablet, 10, blister pack | has TP | Olmesart HCT 20/12.5 (GxP) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR